SYSTIMMUNE ANNOUNCES SECOND APPROVAL OF IZA-BREN IN CHINA FOR THE TREATMENT OF RECURRENT OR METASTATIC ESOPHAGEAL SQUAMOUS CELL CARCINOMA

Reuters · 1d ago

Please log in to view news